{"meshTags":["Indoles","Cell Line, Tumor","Tumor Suppressor Protein p53","Proto-Oncogene Proteins c-mdm2","Stereoisomerism","Transcription, Genetic","Humans","Models, Molecular","Drug Screening Assays, Antitumor","Structure-Activity Relationship","Combinatorial Chemistry Techniques","Protein Binding","Antineoplastic Agents"],"meshMinor":["Indoles","Cell Line, Tumor","Tumor Suppressor Protein p53","Proto-Oncogene Proteins c-mdm2","Stereoisomerism","Transcription, Genetic","Humans","Models, Molecular","Drug Screening Assays, Antitumor","Structure-Activity Relationship","Combinatorial Chemistry Techniques","Protein Binding","Antineoplastic Agents"],"genes":["Small-molecule","MDM2","p53","MDM2","p53","p53-dependent gene","MDM2"],"organisms":["9606"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t"],"abstract":"From a set of weakly potent lead compounds, using in silico screening and small library synthesis, a series of 2-alkyl-3-aryl-3-alkoxyisoindolinones has been identified as inhibitors of the MDM2-p53 interaction. Two of the most potent compounds, 2-benzyl-3-(4-chlorophenyl)-3-(3-hydroxypropoxy)-2,3-dihydroisoindol-1-one (76; IC(50) \u003d 15.9 +/- 0.8 microM) and 3-(4-chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one (79; IC(50) \u003d 5.3 +/- 0.9 microM), induced p53-dependent gene transcription, in a dose-dependent manner, in the MDM2 amplified, SJSA human sarcoma cell line.","title":"Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.","pubmedId":"17034127"}